Discontinued — last reported Q3 '26
Business Segments · Goodwill
Diabetes — Goodwill
Medtronic Diabetes — Goodwill remained flat by 0.0% to $2.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $2.25B to $2.26B. Over 4 years (FY 2021 to FY 2025), Diabetes — Goodwill shows relatively stable performance with a 0.9% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2026Feb 24, 2026
Rolls up toGoodwill
How to read this metric
A significant increase suggests recent acquisition activity, while a decrease may signal impairment charges due to poor segment performance.
Detailed definition
This represents the premium paid over the fair value of net identifiable assets when acquiring businesses within the dia...
Peer comparison
Standard accounting line item found in segment reporting for companies with active M&A strategies.
Metric ID:
mdt_segment_diabetes_goodwillHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.26B | $2.26B | $2.26B | $2.25B | $2.25B | $2.25B | $2.25B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.25B | $2.26B | $2.26B | $2.26B | $2.26B |
| QoQ Change | — | -0.1% | +0.0% | -0.0% | +0.0% | -0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -0.1% | -0.1% | -0.0% | +0.0% | +0.0% | +0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.0% | +0.0% | +0.0% | +0.0% | +0.1% |
Range$2.25B – $2.26B
CAGR-0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak4 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes — goodwill?
- Medtronic (MDT) reported diabetes — goodwill of $2.26B in Q4 2025.
- How has Medtronic's diabetes — goodwill changed year-over-year?
- Medtronic's diabetes — goodwill increased by 0.1% year-over-year, from $2.25B to $2.26B.
- What is the long-term trend for Medtronic's diabetes — goodwill?
- Over 4 years (2021 to 2025), Medtronic's diabetes — goodwill has grown at a 0.9% compound annual growth rate (CAGR), from $8.69B to $9.02B.
- What does diabetes — goodwill mean?
- The intangible asset value recorded when the diabetes segment acquires other companies.